ApoE controls the interface linking lipids and inflammation in atherosclerosis.

Atherosclerosis is a chronic inflammatory disease of the arterial walls that often leads to myocardial infarction and/or stroke. Hypercholesterolemia and an imbalance of peripheral leukocyte counts, leading to arterial leukocyte infiltration, are considered independent risk factors for atherosclerosis. However, in this issue of the JCI, Murphy and colleagues identify a mechanistic link between hypercholesterolemia, leukocytosis, and the subsequent development of atherosclerotic lesions in mice. These findings could pave the way for the development of novel treatment strategies to control leukocyte homeostasis and atherosclerosis.

[1]  D. Rader,et al.  Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression. , 2011, The Journal of clinical investigation.

[2]  A. Tall,et al.  ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation , 2010, Science.

[3]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[4]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[5]  T. Simon,et al.  Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice , 2008, Circulation.

[6]  Daniel J. Rader,et al.  Translating molecular discoveries into new therapies for atherosclerosis , 2008, Nature.

[7]  E. Pamer,et al.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 , 2006, Nature Immunology.

[8]  Oliver Soehnlein,et al.  Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis , 2010, Circulation.

[9]  W. Kannel,et al.  Cholesterol-phospholipid ratio in the prediction of coronary heart disease. The Framingham study. , 1966, The New England journal of medicine.

[10]  S. Lira,et al.  Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2−/− Mice: Evidence for Independent Chemokine Functions in Atherogenesis , 2008, Circulation.

[11]  P. Libby,et al.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.

[12]  M. Chiariello,et al.  Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk prediction. , 2010, Atherosclerosis.

[13]  H. Broxmeyer Chemokines in hematopoiesis , 2008, Current opinion in hematology.

[14]  R. Koenen,et al.  Therapeutic targeting of chemokine interactions in atherosclerosis , 2010, Nature Reviews Drug Discovery.

[15]  D. Williams,et al.  Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. , 1991, Journal of immunology.

[16]  D. Rader,et al.  Novel HDL-directed pharmacotherapeutic strategies , 2011, Nature Reviews Cardiology.

[17]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[18]  P. Ducimetiere,et al.  Monocyte count: a risk factor for coronary heart disease? , 1993, American journal of epidemiology.

[19]  A. Tall,et al.  ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. , 2011, The Journal of clinical investigation.

[20]  F. Tacke,et al.  Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.